Chugai Pharmaceutical Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$770.00 | $636.99 | 13.96% | 9 | $693.31B |
JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | $174.55 | 9.93% | 3 | $372.17B |
ABBV | AbbVie | Outperform |
9
|
$166.42 | $178.42 | 9.66% | 11 | $293.88B |
AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | £165.99 | 34.64% | 16 | £187.73B |
ROG | Roche Holding | Hold |
16
|
CHF237.10 | CHF307.83 | 14.93% | 9 | CHF191.28B |
PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
SAN | Sanofi | Outperform |
16
|
89.17€ | 102.80€ | 22.80% | 9 | 111.47€B |
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$982.29 | $961.26 | 6.89% | 8 | $105.97B |
GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.39B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | $58.15 | 22.64% | 10 | $89.25B |